Skip to main content

Table 3 Composition of Medication Regimens According to Hyperpolypharmacy

From: Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES)

Variable

All

No HPP

HPP

P-value

HF medications, %

30

34

24

<0.001

Non-HF, Cardiovascular medications, %

23

24

21

<0.001

Non-cardiovascular medications, %

48

42

55

<0.001

  1. Abbreviations: HPP Hyperpolypharmacy, HF Heart Failure
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us